MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Left Main Coronary Disease
Current evidence for drug-eluting stent placement in unprotected left main coronary disease.
By Seung-Jung Park, MD, PhD, FACC, and Young-Hak Kim, MD, PhD
PCI for Unprotected Left Main Coronary Artery Stenosis
The impact that data from the SYNTAX and PRECOMBAT trials have had on PCI guidelines.
By Seung-Jung Park, MD, PhD, and Young-Hak Kim, MD, PhD
Long-Term MAIN-COMPARE Data Support DES Versus BMS
August 4, 2009—In Circulation, Young-Hak Kim, MD, et al for the MAIN-COMPARE investigators have published findings on the long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents (DES) compared with bare-metal stents (BMS) (2009;120:400–407).
Long-Term Results Support DES Versus BMS for Unprotected Left Main Coronary Stenting
August 4, 2009—In Circulation, Young-Hak Kim, MD, et al for the MAIN-COMPARE investigators have published findings on the long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents (DES) compared with bare-metal stents (BMS) (2009;120:400-407).
Two Studies Look at Predictive Value of SYNTAX Score
June 25, 2010—In the Journal of the American College of Cardiology: Cardiovascular Interventions, Young-Hak Kim, MD, et al published findings from a study aimed to validate the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) score representing angiographic complexity after unprotected left main coronary artery (ULMCA) revascularization (2010;3:612–623).
PCI in Review: Guidelines and Practice
By Ted E. Feldman, MD, FSCAI, Chief Medical Editor
Left Main and Bifurcation Disease
By Ted E. Feldman, MD, Chief Medical Editor
